Search

everythinglearnresearchcommunity

for

Search:↓

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

Three compounds were found to inhibit a prostate disease-related enzyme and reduce prostate size more effectively than the current treatment, suggesting they could be used for treating benign prostatic hyperplasia.

Combining doxazosin and finasteride is more effective for managing benign prostatic hyperplasia than using either drug alone.

Taking tadalafil and finasteride together is safe and effective for treating urinary symptoms and erectile dysfunction in men with enlarged prostates.

Taking 5-Alpha Reductase Inhibitors before bladder removal surgery might make high-grade bladder tumors less aggressive.

New compounds were made that are promising for prostate cancer therapy.

Dutasteride caused more penile tissue changes than finasteride, possibly increasing erectile dysfunction risk.

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.

Long-term use of dutasteride can cause permanent erectile dysfunction in rats.

Qianliekang and liuweidihuangwan are cheaper for BPH treatment than finasteride and tamsulosin.

Finasteride might lower the risk of low-grade prostate cancer but not high-grade cancer, while alpha-blockers might reduce high-grade cancer risk.

Treatments for urinary symptoms often cause ejaculatory problems.

Minoxidil effectively lowers blood pressure and initially increases plasma renin activity without raising aldosterone levels.

Minoxidil boosts plasma renin activity, influenced by control plasma renin activity and changes in sympathetic tone.

Trazodone and chlorpromazine may help treat sexual dysfunction caused by finasteride and SSRIs.

More men are getting benign prostatic hyperplasia, and there are many treatments, from medication to surgery, with new methods being developed.

Castration is preferred for non-breeding male dogs with BPH, but other treatments are available with specific pros and cons.

WS PRO 160 I 120 mg effectively treats urinary symptoms from BPH with good safety and tolerability.

Tadalafil may reduce the risk of major heart events and blood clots in men with urinary symptoms.

Dutasteride and finasteride can change semen and hormone levels in men.

Dutasteride and finasteride have equal safety for treating BPH without increased heart risk.

5-alpha reductase inhibitors help treat prostate issues in aging men, but their role in cancer prevention is debated.

Some new progesterone derivatives are better at blocking testosterone conversion than a common drug.

Combination therapy for BPH is cost-effective, especially for men with larger prostates.

Blocking the enzyme 5α-reductase can shrink the prostate and help treat enlarged prostate issues.

Finasteride causes fewer sexual side effects than dutasteride in men with BPH.

Compounds 4, 4b, and 4c effectively inhibit an enzyme linked to testosterone conversion without significant toxicity.

Tamsulosin may slightly increase dementia risk compared to other treatments for enlarged prostate.

New nonsteroidal molecules can potentially increase dihydrotestosterone in neurons by blocking certain enzymes, without affecting prostate and seminal vesicle weight.

5α-reductase inhibitors like Finasteride and Dutasteride may help manage prostate cancer by blocking testosterone conversion.